标题
ALK inhibitor-induced bradycardia: A systematic-review and meta-analysis
作者
关键词
Non-small cell lung cancer, ALK inhibitors, Meta-analysis, Bradycardia, Dizziness, Cardio-oncology
出版物
LUNG CANCER
Volume 161, Issue -, Pages 9-17
出版商
Elsevier BV
发表日期
2021-08-31
DOI
10.1016/j.lungcan.2021.08.014
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis
- (2020) Jesse Elliott et al. PLoS One
- Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
- (2020) D. Ross Camidge et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of ALK inhibitors in ALK-rearranged non-small cell lung cancer: A systematic review and meta-analysis
- (2020) Daniel Breadner et al. LUNG CANCER
- First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
- (2020) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
- (2019) Caicun Zhou et al. Lancet Respiratory Medicine
- Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study
- (2018) S Novello et al. ANNALS OF ONCOLOGY
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
- (2018) Andrea C. Tricco et al. ANNALS OF INTERNAL MEDICINE
- Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer
- (2018) Yi-Long Wu et al. Journal of Thoracic Oncology
- First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
- (2017) Jean-Charles Soria et al. LANCET
- Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
- (2017) Toyoaki Hida et al. LANCET
- Ceritinib versus chemotherapy in patients with ALK -rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
- (2017) Alice T Shaw et al. LANCET ONCOLOGY
- Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
- (2017) Solange Peters et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe bradycardia associated with crizotinib
- (2017) Ko Kwan Lung et al. POSTGRADUATE MEDICAL JOURNAL
- Factors associated with sinus bradycardia during crizotinib treatment: a retrospective analysis of two large-scale multinational trials (PROFILE 1005 and 1007)
- (2016) Sai-Hong Ignatius Ou et al. Cancer Medicine
- When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugs
- (2015) Giuseppina Gallucci et al. Expert Review of Anticancer Therapy
- ALK inhibitors in non-small cell lung cancer: the latest evidence and developments
- (2015) Ivana Sullivan et al. Therapeutic Advances in Medical Oncology
- First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
- (2014) Benjamin J. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heart rate decrease during crizotinib treatment and potential correlation to clinical response
- (2013) Sai-Hong Ignatius Ou et al. CANCER
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer
- (2012) Andrew J. Weickhardt et al. CANCER
- Efficacy of EGFR Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer: A Meta-Analysis of 13 Randomized Trials
- (2012) Fausto Petrelli et al. Clinical Lung Cancer
- Asymptomatic Profound Sinus Bradycardia (Heart Rate ≤45) in Non-small Cell Lung Cancer Patients Treated with Crizotinib
- (2011) Sai-Hong Ignatius Ou et al. Journal of Thoracic Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now